NOMAD POWER SOLUTIONS, INC. Legal Fees
NOMAD POWER SOLUTIONS, INC. (NMAD) reported Legal Fees of $35.03 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:LegalFees · last filed 2026-05-14
- NOMAD POWER SOLUTIONS, INC. legal fees for the quarter ending 2026-03-31 was $35.03K, a 37.54% decline year-over-year.
- NOMAD POWER SOLUTIONS, INC. legal fees for the quarter ending 2025-12-31 was $21.85K, a 57.11% decline year-over-year.
- NOMAD POWER SOLUTIONS, INC. legal fees for the quarter ending 2025-09-30 was $16.85K, a 62.89% decline year-over-year.
- NOMAD POWER SOLUTIONS, INC. legal fees for the quarter ending 2025-06-30 was $17.30K, a 72.80% decline year-over-year.
- NOMAD POWER SOLUTIONS, INC. legal fees for fiscal 2025 was $112.09K, a 53.91% decline from fiscal 2024.
- NOMAD POWER SOLUTIONS, INC. legal fees for fiscal 2024 was $243.19K, a 75.14% decline from fiscal 2023.
- NOMAD POWER SOLUTIONS, INC. legal fees for fiscal 2023 was $978.24K, a 22.87% decline from fiscal 2022.
- NOMAD POWER SOLUTIONS, INC. legal fees for fiscal 2022 was $1.27M, a 73.94% increase from fiscal 2021.
| Period end | Legal Fees 0 month | Legal Fees 3 month | Legal Fees 6 month | Legal Fees 9 month | Legal Fees 12 month |
|---|---|---|---|---|---|
| 2026-03-31 | $35.03K 10-Q · filed 2026-05-14 | $56.88K derived: sum of 2 quarters · filed 2026-05-14 | $73.74K derived: sum of 3 quarters · filed 2026-05-14 | $91.04K derived: sum of 4 quarters · filed 2026-05-14 | |
| 2025-12-31 | $21.85K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $38.70K derived: sum of 2 quarters · filed 2026-03-31 | $56.01K derived: sum of 3 quarters · filed 2026-03-31 | $112.09K 10-K · filed 2026-03-31 | |
| 2025-09-30 | $16.85K 10-Q · filed 2025-11-12 | $34.16K derived: sum of 2 quarters · filed 2025-11-12 | $90.24K 10-Q · filed 2025-11-12 | $141.19K derived: sum of 4 quarters · filed 2026-05-14 | |
| 2025-06-30 | $17.30K 10-Q · filed 2025-08-07 | $73.39K 10-Q · filed 2025-08-07 | $124.33K derived: sum of 3 quarters · filed 2026-05-14 | $169.75K derived: sum of 4 quarters · filed 2026-05-14 | |
| 2025-03-31 | $56.08K 10-Q · filed 2026-05-14 | $107.03K derived: sum of 2 quarters · filed 2026-05-14 | $152.45K derived: sum of 3 quarters · filed 2026-05-14 | $216.06K derived: sum of 4 quarters · filed 2026-05-14 | |
| 2024-12-31 | $50.95K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $96.36K derived: sum of 2 quarters · filed 2026-03-31 | $159.97K derived: sum of 3 quarters · filed 2026-03-31 | $243.19K 10-K · filed 2026-03-31 | |
| 2024-09-30 | $45.42K 10-Q · filed 2025-11-12 | $109.03K derived: sum of 2 quarters · filed 2025-11-12 | $192.24K 10-Q · filed 2025-11-12 | $335.12K derived: sum of 4 quarters · filed 2025-11-12 | |
| 2024-06-30 | $63.61K 10-Q · filed 2025-08-07 | $146.82K 10-Q · filed 2025-08-07 | $289.70K derived: sum of 3 quarters · filed 2025-08-07 | $467.72K derived: sum of 4 quarters · filed 2025-08-07 | |
| 2024-03-31 | $83.21K 10-Q · filed 2025-05-12 | $226.09K derived: sum of 2 quarters · filed 2025-05-12 | $404.11K derived: sum of 3 quarters · filed 2025-05-12 | $744.12K derived: sum of 4 quarters · filed 2025-05-12 | |
| 2023-12-31 | $142.88K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | $320.89K derived: sum of 2 quarters · filed 2025-03-24 | $660.90K derived: sum of 3 quarters · filed 2025-03-24 | $978.24K 10-K · filed 2025-03-24 | |
| 2023-09-30 | $178.01K 10-Q · filed 2024-11-12 | $518.02K derived: sum of 2 quarters · filed 2024-11-12 | $835.36K 10-Q · filed 2024-11-12 | $1.16M derived: sum of 4 quarters · filed 2024-11-12 | |
| 2023-06-30 | $340.01K 10-Q · filed 2024-08-08 | $657.35K 10-Q · filed 2024-08-08 | $980.87K derived: sum of 3 quarters · filed 2024-08-08 | $1.25M derived: sum of 4 quarters · filed 2024-08-08 | |
| 2023-03-31 | $317.34K 10-Q · filed 2024-05-09 | $640.86K derived: sum of 2 quarters · filed 2024-05-09 | $912.02K derived: sum of 3 quarters · filed 2024-05-09 | $1.27M derived: sum of 4 quarters · filed 2024-05-09 | |
| 2022-12-31 | $323.52K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | $594.68K derived: sum of 2 quarters · filed 2024-03-19 | $953.07K derived: sum of 3 quarters · filed 2024-03-19 | $1.27M 10-K · filed 2024-03-19 | |
| 2022-09-30 | $271.16K 10-Q · filed 2023-11-09 | $629.55K derived: sum of 2 quarters · filed 2023-11-09 | $944.79K 10-Q · filed 2023-11-09 | $1.31M derived: sum of 4 quarters · filed 2023-11-09 | |
| 2022-06-30 | $358.39K 10-Q · filed 2023-08-09 | $673.63K 10-Q · filed 2023-08-09 | $1.04M derived: sum of 3 quarters · filed 2023-08-09 | $1.17M derived: sum of 4 quarters · filed 2023-08-09 | |
| 2022-03-31 | $315.24K 10-Q · filed 2023-05-10 | $678.94K derived: sum of 2 quarters · filed 2023-05-10 | $816.06K derived: sum of 3 quarters · filed 2023-05-10 | $924.25K derived: sum of 4 quarters · filed 2023-05-10 | |
| 2021-12-31 | $363.70K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $500.82K derived: sum of 2 quarters · filed 2023-03-29 | $609.01K derived: sum of 3 quarters · filed 2023-03-29 | $729.17K 10-K · filed 2023-03-29 | |
| 2021-09-30 | $137.11K 10-Q · filed 2022-11-08 | $245.31K derived: sum of 2 quarters · filed 2022-11-08 | $365.47K 10-Q · filed 2022-11-08 | ||
| 2021-06-30 | $108.19K 10-Q · filed 2022-08-10 | $228.35K 10-Q · filed 2022-08-10 | |||
| 2021-03-31 | $120.16K 10-Q · filed 2022-05-11 | ||||
| 2020-12-31 | $553.17K 10-K · filed 2022-03-21 | ||||
| 2015-03-17 | $12.61K 10-Q · filed 2017-11-09 | ||||
| 2014-12-31 | $12.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-27 | $24.00K derived: sum of 2 quarters · filed 2015-03-27 | $34.00K derived: sum of 3 quarters · filed 2015-03-27 | $46.00K 10-K · filed 2015-03-27 | |
| 2014-09-30 | $12.00K 10-Q · filed 2014-11-12 | $22.00K derived: sum of 2 quarters · filed 2014-11-12 | $34.00K 10-Q · filed 2014-11-12 | $46.00K derived: sum of 4 quarters · filed 2015-03-27 | |
| 2014-06-30 | $10.00K 10-Q · filed 2014-08-08 | $22.00K 10-Q · filed 2014-08-08 | $34.00K derived: sum of 3 quarters · filed 2015-03-27 | ||
| 2014-03-31 | $12.00K derived: 10-K 12 month − 3 quarters · filed 2015-03-27 | $24.00K derived: sum of 2 quarters · filed 2015-03-27 | |||
| 2013-12-31 | $12.00K 10-Q · filed 2014-08-08 | $12.00K 10-K · filed 2015-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B |